BACKGROUND AND OBJECTIVES: Vascular calcification is common and severe in chronic kidney disease. Because the consequences of calcification may differ by vascular beds, we sought to test the hypothesis that patients who have diabetes with proteinuria and have significant renal artery calcification (RAC) have a higher risk for progression to ESRD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using electron-beam computed tomography, RAC was computed as the sum of Agatston scores at each of the two renal ostia and renal arteries. Time-to-event analysis was conducted to compare the risk in individuals with or without significant RAC (total score >10). RESULTS: Of 172 patients with type 2 diabetes and overt proteinuria studied (estimated GFR 56 ± 25 ml/min per 1.73 m(2)), significant RAC was present in 31%. In 33 ± 21 months, 41 progressed to ESRD and 65 reached a composite outcome (ESRD or death). Serum phosphorus was a significant predictor of progression to ESRD but was replaced by the significant RAC in multivariate models that included the latter. Individuals with significant RAC had a higher risk for reaching the composite outcome. In contrast, there was no association between coronary artery calcification scores and progression to ESRD. CONCLUSIONS: Significant RAC was an independent predictor of progression to ESRD as well as reaching the composite outcome. Understanding the pathogenesis of RAC would allow determination of whether this risk is potentially modifiable.
BACKGROUND AND OBJECTIVES:Vascular calcification is common and severe in chronic kidney disease. Because the consequences of calcification may differ by vascular beds, we sought to test the hypothesis that patients who have diabetes with proteinuria and have significant renal artery calcification (RAC) have a higher risk for progression to ESRD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Using electron-beam computed tomography, RAC was computed as the sum of Agatston scores at each of the two renal ostia and renal arteries. Time-to-event analysis was conducted to compare the risk in individuals with or without significant RAC (total score >10). RESULTS: Of 172 patients with type 2 diabetes and overt proteinuria studied (estimated GFR 56 ± 25 ml/min per 1.73 m(2)), significant RAC was present in 31%. In 33 ± 21 months, 41 progressed to ESRD and 65 reached a composite outcome (ESRD or death). Serum phosphorus was a significant predictor of progression to ESRD but was replaced by the significant RAC in multivariate models that included the latter. Individuals with significant RAC had a higher risk for reaching the composite outcome. In contrast, there was no association between coronary artery calcification scores and progression to ESRD. CONCLUSIONS: Significant RAC was an independent predictor of progression to ESRD as well as reaching the composite outcome. Understanding the pathogenesis of RAC would allow determination of whether this risk is potentially modifiable.
Authors: Bryan Kestenbaum; Joshua N Sampson; Kyle D Rudser; Donald J Patterson; Stephen L Seliger; Bessie Young; Donald J Sherrard; Dennis L Andress Journal: J Am Soc Nephrol Date: 2004-12-22 Impact factor: 10.121
Authors: Sharon M Moe; Kalisha D O'Neill; Danxia Duan; Sadiq Ahmed; Neal X Chen; Stephen B Leapman; Naomi Fineberg; Kenyon Kopecky Journal: Kidney Int Date: 2002-02 Impact factor: 10.612
Authors: Rajnish Mehrotra; Matthew Budoff; Peter Christenson; Eli Ipp; Junichiro Takasu; Ajay Gupta; Keith Norris; Sharon Adler Journal: Kidney Int Date: 2004-11 Impact factor: 10.612
Authors: Tulika Jain; Ronald Peshock; Darren K McGuire; DuWayne Willett; Zhoaxia Yu; Zhoazia Yu; Gloria L Vega; Rudy Guerra; Helen H Hobbs; Scott M Grundy Journal: J Am Coll Cardiol Date: 2004-09-01 Impact factor: 24.094
Authors: Barry I Freedman; Fang-Chi Hsu; Carl D Langefeld; Donald W Bowden; Shahriar Moossavi; Bonnie N Dryman; J Jeffrey Carr Journal: Kidney Int Date: 2004-06 Impact factor: 10.612
Authors: Devesh Vashishtha; Robyn L McClelland; Joachim H Ix; Dena E Rifkin; Nancy Jenny; Matthew Allison Journal: Am J Cardiol Date: 2017-07-24 Impact factor: 2.778
Authors: Dena E Rifkin; Joachim H Ix; Christina L Wassel; Michael H Criqui; Matthew A Allison Journal: J Am Coll Cardiol Date: 2012-08-29 Impact factor: 24.094
Authors: Daniel A Roseman; Shih-Jen Hwang; Emily S Manders; Christopher J O'Donnell; Ashish Upadhyay; Udo Hoffmann; Caroline S Fox Journal: Am J Cardiol Date: 2013-10-04 Impact factor: 2.778
Authors: Rajnish Mehrotra; Carmen A Peralta; Shu-Cheng Chen; Suying Li; Michael Sachs; Anuja Shah; Keith Norris; Georges Saab; Adam Whaley-Connell; Bryan Kestenbaum; Peter A McCullough Journal: Kidney Int Date: 2013-04-24 Impact factor: 10.612
Authors: Maryam Afkarian; Leila R Zelnick; John Ruzinski; Bryan Kestenbaum; Jonathan Himmelfarb; Ian H de Boer; Rajnish Mehrotra Journal: J Diabetes Complications Date: 2015-09-02 Impact factor: 2.852